# The public virtual-cell field

Survey conducted 2026-08-21. Three lineages currently use the phrase
"virtual cell" for genuinely different objects: mechanistic whole-cell
simulation (differential equations and stochastic kinetics over an
annotated genome), general-purpose reaction-diffusion platforms (VCell),
and the new AI-virtual-cell program (foundation models trained on
single-cell data). A fourth, older lineage — process calculi and
membrane computing — treats the cell as a formal computational object
rather than a simulation target, and is the closest formal kin to a
membrane/admission-predicate design.

## Whole-cell mechanistic simulation

**Karr et al. 2012.** Jonathan Karr, Jayodita Sanghvi, Derek Macklin,
Miriam Gutschow, Jared Jacobs, Benjamin Bolival, Nacyra Assad-Garcia,
John Glass, and Markus Covert, "A Whole-Cell Computational Model
Predicts Phenotype from Genotype," *Cell* 150(2): 389–401 (2012),
doi:10.1016/j.cell.2012.05.044. Built at Stanford (Covert lab) with
JCVI (Glass), it models *Mycoplasma genitalium*, a 525-kb genome
pathogen with 401 genes — the smallest genome of any free-living
organism known at the time. The model is not one system of equations
but 28 submodels, one per cellular process (DNA replication, RNA and
protein degradation, metabolism, transcriptional regulation, and so
on), each built with the mathematical formalism appropriate to it
(ODEs, stochastic simulation, FBA) and reconciled once per second of
simulated time via a shared cell state. It covers 401 genes, 722
metabolites, 1,857 reactions, and 1,836 parameters, fit against a
literature base of roughly 900 papers. It was the first model to
represent every annotated gene function of an organism and reproduced
population-level statistics like doubling time and biomass composition
without having been fit to them directly. Code and data are at
github.com/CovertLab/WholeCell and simtk.org/projects/wholecell.

**E-Cell**, older by 15 years, is the direct ancestor of the genre.
Launched in 1996 at Keio University by Masaru Tomita, the first E-CELL
release (1997) was a generic reaction-rule simulator with defined
compartments (membrane, cytoplasm, chromosome). By 1997–99, in
collaboration with TIGR, it produced a prototype 127-gene virtual
*Mycoplasma genitalium* — explicitly framed by Tomita as a "grand
challenge" for the field over a decade before Karr's paper delivered
on it. E-Cell went through versions 2 (Windows port by Naota Ishikawa)
and 3 (a more general simulation environment); the project's own
framing of whole-cell simulation as a named grand challenge is recorded
in Tomita's 2001 *Trends in Biotechnology* piece, "Whole-cell
simulation: a grand challenge of the 21st century."

**Successors after 2012.** There are now three published whole-cell
models properly so called, plus a fourth for a eukaryote:

- *E. coli*, from the Covert lab: Derek Macklin et al., "Simultaneous
  cross-evaluation of heterogeneous E. coli datasets via mechanistic
  simulation," *Science* 369 (2020), covering 1,214 genes (over 40% of
  well-annotated E. coli genes) and roughly 19,000 parameters. Later
  updates added ppGpp-mediated growth-rate control, amino-acid
  biosynthesis dynamics, tRNA aminoacylation, codon-resolved
  translation elongation, and N-terminal methionine cleavage — closing
  gaps between the model and known regulatory physiology piece by
  piece rather than in one release.
- *JCVI-syn3A*, the minimal synthetic cell (493 genes, built by
  Hutchison, Glass, and Venter's group by paring the *M. mycoides*
  genome to near-minimal content): Zane Thornburg, David Bianchi, et
  al. (Luthey-Schulten lab, UIUC, with JCVI and TU Dresden),
  "Fundamental behaviors emerge from simulations of a living minimal
  cell," *Cell* 185(2): 345–360 (2022). It uses cryo-electron
  tomograms for actual cell geometry and ribosome placement and
  couples stochastic and deterministic solvers across a full division
  cycle — the first whole-cell model built directly from
  cryo-EM-derived 3-D structure. A 2026 follow-up from the same group,
  "Bringing the genetically minimal cell to life on a computer in 4D,"
  extends this toward spatial 4-D (space + time) whole-cell dynamics.
- *Saccharomyces cerevisiae*, the first eukaryotic whole-cell model:
  Ye et al. (2020), WM_S288C, built on the iTO977 metabolic
  reconstruction, covering 15 cellular states and 26 processes across
  100% of the annotated genome (6,447 genes) — though "100% of genome"
  here means every gene is represented in some submodel, not that
  every gene product's mechanism is independently validated. A Nature
  paper, "Towards the construction of a virtual yeast" (2026), reports
  continued work in this direction.
- Applied uses: whole-cell models have been used to design reduced
  ("minimal") genomes computationally — Nature Communications 2020 and
  a 2023–2025 line of work (bioRxiv 2023.10.30.564402, published in
  *Cell Systems* 2025) that couples the E. coli WCM to machine learning
  to accelerate genome-reduction design cycles — and to simulate
  antibiotic response heterogeneity across whole colonies of
  individually-simulated E. coli cells (PubMed 37327241, 2023).

**State of the field, per the 2023 review** "Multi-scale models of
whole cells: progress and challenges" (*Frontiers in Cell and
Developmental Biology*, 2023): whole-cell models are necessarily
hybrid — no single formalism covers metabolism (FBA), gene expression
(stochastic simulation at low copy number), and bulk chemistry (ODEs)
at once, so submodels of different kinds are integrated by shared
state, sometimes via Vivarium's discrete-event orchestration (below).
The review names three unresolved problems: data (missing kinetic
parameters, inconsistent measurement conditions, poor annotation for
non-model organisms), integration (no clean way to synchronize
processes with very different natural timescales — DNA replication
takes hours, small-molecule diffusion takes microseconds), and speed
(current whole-cell simulators are not well parallelized and a single
simulated division cycle can take substantial wall-clock time).

## VCell — the general-purpose platform

Virtual Cell (VCell) is a different kind of thing from a whole-cell
model: it is not one organism's mechanism but a modeling *environment*
any cell biologist can use to build their own reaction-diffusion model
of a process. Developed at the R.D. Berlin Center for Cell Analysis
and Modeling at UConn Health, led by biophysicist Leslie Loew and
funded as a National Resource for Cell Analysis and Modeling by NIGMS.
First described by Schaff et al. in *Biophysical Journal* (1997) as "a
general computational framework for modeling cellular structure and
function," with the software itself first released October 11, 1999 —
making it, by a wide margin, the field's oldest continuously
maintained platform (26+ years as of 2026).

What it actually does: VCell couples reaction kinetics to membrane
transport and diffusion across geometries that can be idealized shapes,
combinations of analytic solids, or segmented straight out of
microscope image stacks (nucleus, mitochondria, cytosol boundaries
drawn from real micrographs). A single model can be run through six
different mathematical treatments depending on what the question
needs: compartmental ODEs, spatial reaction-diffusion-advection PDEs
(two solvers), the Gillespie stochastic simulation algorithm and
variants (four solvers), spatial stochastic simulation via an embedded
Smoldyn engine, hybrid deterministic/stochastic runs, and network-free
(rule-based) agent simulation. It supports coupling electrophysiology
to reaction-diffusion, useful for anything where membrane potential and
chemistry interact (calcium signaling, synaptic events). Models and
results are stored in a public, searchable VCell database with
per-model privacy controls, so a paper's model can be cited and rerun
rather than merely described. It is used across a wide span — from
bench cell biologists building one pathway's spatial model to
theoretical biophysicists — and it is explicitly a tool for *modeling a
process someone specifies*, not a machine-learned or a
pre-built whole-organism mechanism.

## The AI-virtual-cell wave

**Bunne et al., "How to Build the Virtual Cell with Artificial
Intelligence: Priorities and Opportunities."** Charlotte Bunne, Yusuf
Roohani, Yanay Rosen, and 39 further co-authors including Aviv Regev
and Arc Institute's Patrick Hsu, arXiv:2409.11654 (submitted September
18, 2024; revised October 14, 2024), published in *Cell* in December
2024 (doi:10.1016/j.cell.2024.11.011). This is the field's manifesto
for the AI approach: it defines a "virtual cell" as a high-fidelity
simulation "learned directly from biological data across measurements
and scales" rather than assembled from known mechanism, proposes a
data–model–interaction architecture (universal representations of
cells and molecules; models that can be queried like virtual
instruments; standardized interaction and evaluation protocols), and
calls for community infrastructure — shared benchmarks, data
standards, and open model weights — comparable to what AlphaFold did
for structure prediction. It is explicitly a *program*, not a
delivered system: no such model exists yet at the scale the paper
describes.

**Foundation models already built toward this goal** are trained not on
mechanism but on large corpora of single-cell RNA-sequencing data,
learning gene-gene and cell-state relationships as embeddings:

- **scGPT** (2023), a transformer masked-language model pretrained on
  over 33 million human cells across tissues and conditions, used for
  cell-type annotation, batch integration, and — via fine-tuning —
  predicting the transcriptomic effect of a perturbation.
- **Geneformer** (Theodoris et al., originally 2023, from the
  Broad/Ellinor lab), pretrained similarly, used for gene-network
  inference and repurposed for perturbation-response prediction though
  not originally designed for it.
- Related models explicitly built around perturbation prediction:
  scFoundation, GeneCompass, AIDO.Cell.

A hard finding across multiple 2024–2025 benchmarking papers
(PertEval-scFM; "Benchmarking Transcriptomics Foundation Models for
Perturbation Analysis: one PCA still rules them all," arXiv:2410.13956;
scFME) is that these large pretrained models show only limited
improvement over much simpler baselines — plain PCA-based linear
methods, or the earlier graph-based GEARS model — at the actual task
of predicting a cell's transcriptomic response to a genetic
perturbation it wasn't trained on. Scale of pretraining has not yet
translated cleanly into the causal generalization the Bunne et al.
manifesto asks for.

**Arc Institute's Virtual Cell Challenge** (launched June 2025,
$100,000 grand prize) operationalizes the same ambition as a public
competition: predict how H1 human embryonic stem cells respond
transcriptionally to genetic perturbations, scored against a new
300,000-cell, 300-perturbation dataset Arc built for the purpose. A
companion *Cell* piece, "Virtual Cell Challenge: Toward a Turing test
for the virtual cell" (2025), frames the whole enterprise explicitly as
needing a Turing-test-like criterion — a model that behaves as if it
understood the cell, judged behaviorally — precisely because no
first-principles ground truth for "the virtual cell" yet exists to
validate against.

**CZI's Virtual Cells Platform** (Chan Zuckerberg Initiative, expanded
with NVIDIA from 2025) is the field's emerging shared infrastructure
rather than a single model: it hosts trained models (including scGPT),
an open benchmarking package (cz-benchmarks) with six standard tasks
(clustering, cell-type classification, cross-species integration,
perturbation-expression prediction, pseudo-temporal ordering,
cross-species disease-label transfer), each scored on multiple metrics
rather than one scalar, plus a reasoning model (rBio) trained on
virtual-cell simulation traces. Its 2025 workshop report,
"Benchmarking and Evaluation of AI Models in Biology" (arXiv:2507.10502),
is candid that the field still lacks a third-party, cross-lab
reproducibility standard and that regulatory bodies have no settled
review process for AI-derived biological claims.

Papers with titles like "Virtual Cells as Causal World Models: A
Perspective on Evaluation" and "Virtual Cells: Predict, Explain,
Discover" (both 2025) make the field's central self-criticism
explicit: current benchmarks reward pattern-matching accuracy (MSE,
R²) on held-out data rather than testing whether the model's response
to a genuinely novel intervention is *causally* correct — the
distinction between predicting and understanding is treated as open
and unresolved, not settled in either direction.

A subreddit named r/virtualcell could not be confirmed to exist as a
notable, documented community during this survey; if the estate wants
that thread of discourse specifically, it would need direct browsing
rather than search-engine discovery. The functioning equivalent of a
public community forum for this field at present is the CZI Virtual
Cells Platform's own micro-publication feed and workshop write-ups,
plus venues like the AI4D3 workshop series, rather than a Reddit
community.

## Agent-based and membrane-computing traditions

These predate the AI wave by 15–25 years and treat "the cell" as a
formal computational structure to be reasoned about, not a numeric
system to be fit and run.

**P systems / membrane computing.** Introduced by Gheorghe Păun in
1998 (foundational paper "Computing with Membranes," and the standard
reference text *Membrane Computing: An Introduction*, Springer 2002).
A P system is a nested hierarchy of membranes (literally modeled on the
cell-within-organelle-within-cell containment of real biology), each
membrane enclosing a multiset of symbolic objects and a set of
evolution rules that can transform objects, move them across
membranes (in/out communication rules), or dissolve/create membranes
themselves. Computation proceeds by maximally parallel, nondeterministic
rewriting: at each step, every membrane applies as many of its
applicable rules as possible, all objects it holds are consumed and
regenerated simultaneously, and the system halts when no membrane has
an applicable rule left, with the "output" read off a designated
membrane's final contents. Păun's stated motivation was explicitly
biological — asking what a cell's compartment structure computes, not
just what it contains — and the field grew into three broad variants:
cell-like P systems (nested, tree-structured), tissue-like P systems
(cells arranged in a graph, communicating directly), and neural-like P
systems. Its research center of gravity is computational — proving
what class of problems a given P-system variant can solve, its
complexity class, whether variants are Turing-complete — rather than
fitting or predicting the behavior of any specific real organism.

**Brane calculi.** Luca Cardelli, "Brane Calculi: Interactions of
Biological Membranes," CMSB 2004 (Paris), published in *LNCS* 3082
(2005), pp. 257–280. Where P systems put the active computation
*inside* membrane-bounded regions and treat the membrane mostly as a
boundary, brane calculi put the computation *on the membrane itself*:
its primitives (Phago/Exo/Pino, "PEP") are literally named after and
modeled on phagocytosis, exocytosis, and pinocytosis — a membrane
engulfing external material, expelling internal material, or budding
inward. An alternative primitive set, Mate/Bud/Drip (MBD), models
membrane fusion and fission and is shown encodable in PEP. Cardelli's
explicit framing: "active entities are tightly coupled to membranes,
and can perform interactions on both sides of a membrane" —
computation is a property of the membrane surface as a
two-sided object, not of the volume it bounds. This is a deliberate
departure from process calculi (like the pi-calculus) where
compartments are just scoping boundaries for otherwise
membrane-independent processes.

**Stochastic pi-calculus.** Aviv Regev, William Silverman, and Ehud
Shapiro, "Representation and simulation of biochemical processes using
the pi-calculus process algebra," *Pacific Symposium on Biocomputing*
(2001), and Regev and Shapiro's 2004 survey "The pi-calculus as an
Abstraction for Biomolecular Systems." The core move is to represent a
molecule as a concurrent process and a binding interaction as a
communication (channel send/receive) between processes — molecular
biology's central metaphor ("molecules as computing agents,
interactions as computation") made formally literal, with Gillespie's
1977 stochastic simulation algorithm supplying rate semantics for the
calculus's nondeterministic choice. Regev, Panina, Silverman, Cardelli,
and Shapiro extended this to explicit compartments in BioAmbients
(2004), and Cardelli and others have since cross-encoded BioAmbients,
brane calculi, and P systems into each other and into bigraphs — a
sign the three formalisms are understood by their own practitioners as
siblings expressing overlapping ideas about compartmentalized
computation, not as competitors.

**Particle-based spatial simulators.** Where the calculi above reason
about compartments symbolically, Smoldyn and MCell simulate individual
molecules as literal diffusing point particles in continuous 3-D
space, reacting on collision. MCell (Joel Stiles and Tom Bartol, 1991)
was the first major such program and remains heavily used in
computational neuroscience for synaptic signaling. Smoldyn (Steve
Andrews, first release 2004) followed, aiming for higher accuracy and
speed than MCell and the ChemCell package it was benchmarked against;
it now supports rule-based reaction definitions, excluded-volume
particles, accurate on-surface diffusion, and single-particle
tracking, with a library interface for embedding it in other tools.
VCell embeds Smoldyn directly as one of its spatial-stochastic solvers
— the concrete point where the "general platform" and "particle
physics" lineages meet.

## What the field lacks, and where it disagrees

**Mechanism versus learned models.** This is the field's live fault
line, not a settled matter. Whole-cell models (Karr-lineage) encode
known biochemical mechanism directly and are interpretable submodel by
submodel, but are expensive to build (each new organism is years of
literature curation) and only as complete as current biological
knowledge. AI virtual-cell models (Bunne-lineage) can be trained on
data at a scale no curation team can match, but multiple 2024–2025
benchmarks show they underperform much simpler statistical baselines
at genuinely novel perturbation prediction, and their internal
representations are not mechanistically interpretable in the way a
whole-cell submodel is. Neither lineage currently subsumes the other;
hybrid work (Vivarium coupling mechanistic submodels to learned
components; machine-learning-accelerated whole-cell genome design) is
early.

**Validation.** The 2025 "Turing test for the virtual cell" framing
from Arc Institute is a direct admission that the field has no
first-principles ground truth to validate a virtual cell against — it
proposes behavioral adequacy (does the model's response to
intervention match a real cell's) as the working criterion instead.
CZI's 2025 workshop report separately flags that different labs use
different data sources, architectures, and validation protocols with
no shared third-party benchmark, and that regulators have no settled
review process for AI-derived biological claims — both an
infrastructure gap and, for anything downstream in drug development or
biosafety review, a governance gap.

**Interoperability.** SBML (Systems Biology Markup Language, current
release Level 3 Version 2 Core) is the field's actual shared standard:
an XML-based, tool-independent format for exchanging biochemical
network models (reactions, species, compartments, kinetic laws) so
that a model built in one tool can be loaded and rerun in another
without translation error. It has companions — CellML (a differently
structured mathematical-model exchange format) and SED-ML (Simulation
Experiment Description Markup Language, which standardizes *how a
simulation was run*, not just what the model is, so a result can be
reproduced exactly). None of the three AI-virtual-cell foundation
models above emit or consume SBML — their outputs are learned
embeddings and predicted expression vectors, not mechanistic reaction
networks, so the older interoperability standard and the new AI models
currently talk past each other entirely.

**Compositionality.** Vivarium (Eran Agmon et al., UConn Health/Covert
lab lineage; *Bioinformatics* 2022) is the field's most direct answer
to "how do you combine submodels of different mathematical kinds into
one whole-cell simulation without hand-wiring every pair." It defines
processes and stores as composable units that can be nested
hierarchically and orchestrated across mismatched timescales
(discrete-event scheduling coordinating ODE, stochastic, FBA, and
agent-based submodels), and its flagship demonstration is a Vivarium
reimplementation of the *E. coli* whole-cell model integrating over a
dozen mechanistic submodels. Its own authors report a real limitation,
though: encoding compositional structure directly in Python code
"limited transparency, interoperability, and reuse" — which has
motivated newer, more formal follow-on work ("process bigraphs,"
arXiv:2512.23754, and "Foundations of a Compositional Systems Biology,"
arXiv:2408.00942) trying to give composition itself a
language-independent mathematical semantics, closer in spirit to how
P systems and brane calculi already specify composition formally.

## Where a semiotic/relational cell simulator would sit

Against this map, a simulator built on membranes as admission
predicates, metabolism as evidence-charged settling, and paraconsistent
internal state is not a variant of any of the four active lineages
above — it doesn't compete with Karr-style mechanism (it isn't fitting
a real organism's biochemistry), VCell (it isn't a general
reaction-diffusion solver), or the AI-virtual-cell program (it isn't
learned from single-cell measurement data at all). Its actual
neighbors are the two formalisms that already treat the cell as a
computational object rather than a numeric one:

- **P systems** are the closer kin structurally: both are built from
  nested, bounded regions holding contents and governed by local
  rules, and both treat the *membrane arrangement itself* as doing
  real work rather than as passive packaging. But P-system membranes
  are permeable by rule-application alone — an object crosses because
  some rule says "send this out," with no notion of the membrane
  itself judging or admitting the object based on what it *is*
  epistemically. A membrane-as-admission-predicate design makes the
  membrane an evaluator, not just a boundary a rule happens to name —
  closer to how a real cell membrane's receptors and channels *decide*
  what crosses based on molecular recognition, which P systems abstract
  away entirely in favor of symbolic multiset rewriting.
- **Brane calculi** are the closer kin in spirit: Cardelli's explicit
  point is that computation belongs to the membrane surface, two-sided,
  not to the volume it bounds — which is structurally the same claim
  an admission-predicate membrane makes. What brane calculi lack that
  such a design would add is any treatment of *uncertain or
  contradictory* internal state: PEP and MBD are classical rewriting
  systems where an object's presence or absence is a fact, not a
  claim with a truth-value that a paraconsistent logic must
  reconcile. Brane calculi have no concept of evidence, charge, or
  settling — a membrane interaction either fires or it doesn't; there
  is no notion of a metabolic process resolving a *conflict* between
  incompatible readings of cell state.
- The stochastic pi-calculus/BioAmbients lineage is a more distant
  cousin: it shares the idea of molecules-as-agents and
  compartments-as-scope, but its semantics are still classical and
  probabilistic (Gillespie rates), not paraconsistent — it models
  *how likely* a reaction is, never *whether the cell's own state
  about itself is internally consistent*.
- None of Karr-style mechanism, VCell, or the AI-foundation-model
  program have any construct analogous to paraconsistency at all —
  they are built on the assumption that cell state, however uncertain
  empirically, is in principle a single consistent numeric vector at
  any instant. A design in which the cell can hold and act on
  admittedly contradictory internal readings — where "evidence
  charging" is the mechanism that eventually resolves (or
  deliberately fails to resolve) that contradiction — has no
  counterpart anywhere in this survey. That is the genuine novelty:
  not the membrane structure (P systems and brane calculi got there
  first, decades ago) but treating metabolism itself as an epistemic
  settling process over a state that is allowed, for a time, to
  disagree with itself.

## Sources

- Karr, J.R. et al. "A Whole-Cell Computational Model Predicts
  Phenotype from Genotype." *Cell* 150(2):389–401 (2012).
  https://doi.org/10.1016/j.cell.2012.05.044
- CovertLab/WholeCell (GitHub); SimTK Whole-Cell project page.
- Tomita, M. "Whole-cell simulation: a grand challenge of the 21st
  century." *Trends in Biotechnology* (2001); e-cell.org/about.html.
- Macklin, D.N. et al. "Simultaneous cross-evaluation of heterogeneous
  E. coli datasets via mechanistic simulation." *Science* 369 (2020).
- Thornburg, Z.R., Bianchi, D.M. et al. "Fundamental behaviors emerge
  from simulations of a living minimal cell." *Cell* 185(2):345–360
  (2022). https://doi.org/10.1016/j.cell.2021.12.025
- Ye, C. et al. WM_S288C yeast whole-cell model (2020); "Towards the
  construction of a virtual yeast," *Nature* (2026).
- "Multi-scale models of whole cells: progress and challenges."
  *Frontiers in Cell and Developmental Biology* (2023).
- Schaff, J. et al. *Biophysical Journal* (1997); VCell,
  vcell.org; Wikipedia, "VCell."
- Bunne, C. et al. "How to Build the Virtual Cell with Artificial
  Intelligence: Priorities and Opportunities." arXiv:2409.11654;
  *Cell* (2024).
- scGPT (2023); Geneformer (Theodoris et al.); PertEval-scFM and
  arXiv:2410.13956 benchmarking papers (2024).
- Arc Institute, "Virtual Cell Challenge 2025" (arcinstitute.org);
  "Virtual Cell Challenge: Toward a Turing test for the virtual cell,"
  *Cell* (2025).
- CZI Virtual Cells Platform (virtualcellmodels.cziscience.com);
  "Benchmarking and Evaluation of AI Models in Biology," arXiv:2507.10502.
- Păun, G. "Computing with Membranes" (1998); *Membrane Computing: An
  Introduction* (Springer, 2002).
- Cardelli, L. "Brane Calculi: Interactions of Biological Membranes."
  CMSB 2004 / LNCS 3082 (2005), 257–280.
- Regev, A., Silverman, W., Shapiro, E. "Representation and simulation
  of biochemical processes using the pi-calculus process algebra."
  *Pacific Symposium on Biocomputing* (2001); Regev & Shapiro, "The
  pi-calculus as an Abstraction for Biomolecular Systems" (2004);
  Regev et al., BioAmbients (2004).
- Stiles, J., Bartol, T. MCell (1991, ongoing); Andrews, S. Smoldyn
  (2004, ongoing); "Detailed Simulations of Cell Biology with Smoldyn
  2.1," *PLOS Computational Biology* (2010).
- Agmon, E. et al. "Vivarium: an interface and engine for integrative
  multiscale modeling in computational biology." *Bioinformatics*
  38(7):1972 (2022); "Foundations of a Compositional Systems Biology,"
  arXiv:2408.00942; "Process Bigraphs," arXiv:2512.23754.
- SBML Level 3 Version 2 Core specification; CellML; SED-ML.
